Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-26

Clinical Trial Update: Spondyloarthritis: Inducing Drug-free Remission by Early TNF-alpha Blockade [Phase 3]

View source ↗

Summary

Phase 3 trial update examining whether early TNF-alpha blockade can induce drug-free remission in peripheral spondyloarthritis; the study is currently active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TNF-alpha inhibitors (TNF-alpha inhibitor)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Peripheral Spondyloarthritis | Phase 3 | Status: ACTIVE_NOT_RECRUITING